BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 24447714)

  • 21. Accuracy of gadofosveset-enhanced MRI for nodal staging and restaging in rectal cancer.
    Lambregts DM; Beets GL; Maas M; Kessels AG; Bakers FC; Cappendijk VC; Engelen SM; Lahaye MJ; de Bruïne AP; Lammering G; Leiner T; Verwoerd JL; Wildberger JE; Beets-Tan RG
    Ann Surg; 2011 Mar; 253(3):539-45. PubMed ID: 21239980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beyond total mesorectal excision in locally advanced rectal cancer with organ or pelvic side-wall involvement.
    Mariathasan AB; Boye K; Giercksky KE; Brennhovd B; Gullestad HP; Emblemsvåg HL; Grøholt KK; Dueland S; Flatmark K; Larsen SG
    Eur J Surg Oncol; 2018 Aug; 44(8):1226-1232. PubMed ID: 29691115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intermediate-fraction neoadjuvant radiotherapy for rectal cancer.
    Zhan T; Gu J; Li M; Du C
    Dis Colon Rectum; 2013 Apr; 56(4):422-32. PubMed ID: 23478609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo cancer de recto 3 study.
    Fernández-Martos C; Pericay C; Aparicio J; Salud A; Safont M; Massuti B; Vera R; Escudero P; Maurel J; Marcuello E; Mengual JL; Saigi E; Estevan R; Mira M; Polo S; Hernandez A; Gallen M; Arias F; Serra J; Alonso V
    J Clin Oncol; 2010 Feb; 28(5):859-65. PubMed ID: 20065174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative chemoradiotherapy improves local recurrence free survival in locally advanced rectal cancer.
    Tural D; Ozturk M; Selcukbiricik F; Yildiz O; Elicin O; Turna H; Guney S; Ozguroglu M
    J BUON; 2013; 18(2):385-90. PubMed ID: 23818350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of carcinoembryonic antigen after neoadjuvant chemoradiotherapy in patients with rectal cancer.
    Jang NY; Kang SB; Kim DW; Kim JH; Lee KW; Kim IA; Kim JS
    Dis Colon Rectum; 2011 Feb; 54(2):245-52. PubMed ID: 21228676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rectal cancer: MR imaging before neoadjuvant chemotherapy and radiation therapy for prediction of tumor-free circumferential resection margins and long-term survival.
    Wieder HA; Rosenberg R; Lordick F; Geinitz H; Beer A; Becker K; Woertler K; Dobritz M; Siewert JR; Rummeny EJ; Stollfuss JC
    Radiology; 2007 Jun; 243(3):744-51. PubMed ID: 17463134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognosis factors for recurrence in patients with locally advanced rectal cancer preoperatively treated with chemoradiotherapy and adjuvant chemotherapy.
    Arredondo J; Baixauli J; Beorlegui C; Arbea L; Rodríguez J; Sola JJ; Chopitea A; Hernández-Lizoáin JL
    Dis Colon Rectum; 2013 Apr; 56(4):416-21. PubMed ID: 23478608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative outcome between chemoradiotherapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer.
    Kim JC; Takahashi K; Yu CS; Kim HC; Kim TW; Ryu MH; Kim JH; Mori T
    Ann Surg; 2007 Nov; 246(5):754-62. PubMed ID: 17968166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short-term outcome after neoadjuvant high-dose-rate endorectal brachytherapy or short-course external beam radiotherapy in resectable rectal cancer.
    Hesselager C; Vuong T; Påhlman L; Richard C; Liberman S; Letellier F; Folkesson J
    Colorectal Dis; 2013 Jun; 15(6):662-6. PubMed ID: 23461819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma.
    Peeters KC; Marijnen CA; Nagtegaal ID; Kranenbarg EK; Putter H; Wiggers T; Rutten H; Pahlman L; Glimelius B; Leer JW; van de Velde CJ;
    Ann Surg; 2007 Nov; 246(5):693-701. PubMed ID: 17968156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes of multimodality therapies for patients with stage II or III rectal cancer in California, 1994-2009.
    Cho MM; Morgan JW; Knutsen R; Oda K; Shavlik D; Knutsen S; Kazanjian K
    Dis Colon Rectum; 2013 Dec; 56(12):1357-65. PubMed ID: 24201389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What is the significance of a microscopically positive resection margin in the curative-intent treatment of rectal adenocarcinoma? A retrospective study.
    Fekete Z; Muntean A; Irimie A; Hica S; Resiga L; Todor N; Nagy V
    J BUON; 2013; 18(4):989-95. PubMed ID: 24344028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Low anterior resection of the rectum with total mesorectal excision--immediate results].
    Radu I; Anitei G; Scripcariu V; Dragomir C
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):460-5. PubMed ID: 21870741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Downstaging after neoadjuvant therapy for rectal cancer modifies the planned original surgery].
    Scutari F; Tramutola G; Morlino A; Rossi MT; Manzione L; Rosati G; Sopranzi A
    G Chir; 2008; 29(6-7):277-80. PubMed ID: 18544264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade.
    Wheeler JM; Dodds E; Warren BF; Cunningham C; George BD; Jones AC; Mortensen NJ
    Dis Colon Rectum; 2004 Dec; 47(12):2025-31. PubMed ID: 15657650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bowel dysfunction after low anterior resection with and without neoadjuvant therapy for rectal cancer: a population-based cross-sectional study.
    Bregendahl S; Emmertsen KJ; Lous J; Laurberg S
    Colorectal Dis; 2013 Sep; 15(9):1130-9. PubMed ID: 23581977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Local excision in early rectal cancer-outcome worse than expected: a population based study.
    Saraste D; Gunnarsson U; Janson M
    Eur J Surg Oncol; 2013 Jun; 39(6):634-9. PubMed ID: 23414776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Histologic response after neoadjuvant therapy in rectal adenocarcinoma: own experience and review of the literature].
    Mátrai Z; Lövey J; Hitre E; Orosz Z; Gödény M; Péley G; Sulyok Z; Rényi Vámos F; Farkas E; Köves I
    Orv Hetil; 2006 Oct; 147(42):2011-20. PubMed ID: 17165600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.
    Beddy D; Hyland JM; Winter DC; Lim C; White A; Moriarty M; Armstrong J; Fennelly D; Gibbons D; Sheahan K
    Ann Surg Oncol; 2008 Dec; 15(12):3471-7. PubMed ID: 18846402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.